| PERIOD ENDING | 24-Oct-09 | 25-Jul-09 | 25-Apr-09 | 24-Jan-09 | | Total Revenue | 814,951 | 789,579 | 779,884 | 811,023 | | Cost of Revenue | 548,414 | 530,895 | 510,774 | 541,914 | | | Gross Profit | 266,537 | 258,684 | 269,110 | 269,109 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 182,051 | 181,894 | 176,622 | 177,567 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 84,486 | 76,790 | 92,488 | 91,542 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,598 | 2,261 | 510 | 255 | | Earnings Before Interest And Taxes | 87,084 | 79,051 | 92,998 | 91,797 | | Interest Expense | 6,358 | 6,619 | 6,914 | 7,000 | | Income Before Tax | 80,726 | 72,432 | 86,084 | 84,797 | | Income Tax Expense | 31,383 | 27,375 | 32,123 | 31,990 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 49,343 | 45,057 | 53,961 | 52,807 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 49,343 | 45,057 | 53,961 | 52,807 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $49,343 | $45,057 | $53,961 | $52,807 |
|
0.51% Nasdaq 
0.13 (0.47%) 
Income Statement
